Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 6, 2007, Pages 745-750

  Hsieh, Ming Chia ^a,b   Tien, Kai Jen ^a   Chang, Shun Jen ^b   Lo, Chao Sheng ^b   Hsin, Shih Chieh ^a   Hsiao, Jeng Yueh ^a   Hsu, Shih Chieh ^a   Liang, Hui Ting ^a   Chen, Hung Chun ^a   Shin, Shyi Jang ^a,b   Lin, Shiu Ru ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

ADULT; AGED; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 34248340519     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.023     Document Type: Article

References (43)

1. Pyorala K., Ml L., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3 (1987) 463-524
2. Dunn F.L. Hyperlipidemia in diabetes mellitus. Diabetes Metab Rev 6 (1990) 47-61
3. Gotto Jr. A.M. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation 103 (2001) 2213-2218
4. Turner R.C., et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316 (1998) 823-828
5. Bhatnagar D., et al. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 98 (1993) 25-32
6. Lagrost L., and Gambert P. HDL and reverse cholesterol transport. Role of cholesterol ester transfer protein. C R Seances Soc Biol Fil 186 (1992) 405-413
7. Inazu A., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323 (1990) 1234-1238
8. Inazu A., et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94 (1994) 1872-1882
9. Drayna D., and Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 15 (1987) 4698
10. Freeman D., et al. An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 17 (1989) 2880
11. Zuliani G., and Hobbs H.H. EcoN I polymorphism in the human cholesteryl ester transfer protein (CEPT) gene. Nucleic Acids Res 18 (1990) 2834
12. Freeman D.J., et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14 (1994) 336-344
13. Kuivenhoven J.A., et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17 (1997) 560-568
14. Elosua R., et al. Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: the Framingham Heart Study. Atherosclerosis 189 (2006) 222-228
15. Ordovas J.M., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20 (2000) 1323-1329
16. Eiriksdottir G., et al. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 159 (2001) 187-192
17. Corbex M., et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19 (2000) 64-80
18. Park K.W., et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet 63 (2003) 31-38
19. Radeau T., et al. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients. Nephron 84 (2000) 333-341
20. Tso D.K., and Moe G. Cardiovascular disease in Chinese Canadians: a case-mix study from an urban tertiary care cardiology clinic. Can J Cardiol 18 (2002) 861-869
21. Mak K.H., et al. Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J 24 (2003) 151-160
22. Chi Z.S., et al. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl 2 (2001) S82-S86
23. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
24. Contois J.H., et al. Quantitative determination of cholesterol in lipoprotein fractions by electrophoresis. Clin Chim Acta 282 (1999) 1-14
25. Cannings C., and Edwards A.W. Expected genotypic frequencies in a small sample: deviation from Hardy-Weinberg equilibrium. Am J Hum Genet 21 (1969) 245-247
26. Kawasaki I., et al. Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes 51 (2002) 871-874
27. Meguro S., et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 156 (2001) 151-156
28. Chaaba R., et al. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients. Clin Biochem 38 (2005) 373-378
29. Boekholdt S.M., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
30. Kuivenhoven J.A., et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338 (1998) 86-93
31. Blankenberg S., et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol 41 (2003) 1983-1989
32. Hsu L.A., et al. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 110 (2002) 57-63
33. Relvas W.G., Izar M.C., Helfenstein T., Fonseca M.I., Colovati M., Oliveira A., et al. Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects. Atherosclerosis 178 (2005) 101-105
34. Kauma H., et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 97 (1996) 156-162
35. Durlach A., et al. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 84 (1999) 3656-3659
36. Chen J., et al. Association of human cholesteryl ester transfer protein-TaqI polymorphisms with serum HDL cholesterol levels in a normolipemic Japanese rural population. J Epidemiol 12 (2002) 77-84
37. Vohl M.C., et al. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome. Int J Obes Relat Metab Disord 23 (1999) 918-925
38. Culleton B.F., et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214-2219
39. Henry R.M., et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 62 (2002) 1402-1407
40. Wannamethee S.G., Shaper A.G., and Perry I.J. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 28 (1997) 557-563
41. Mann J.F., et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
42. Adler A.I., et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63 (2003) 225-232
43. Ukkola O., et al. DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 46 (1994) 217-227